Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. Part 2: Synthesis of novel triplet drugs with the epoxymethano structure (capped homotriplet)

被引：9

作者：

Nagase, Hiroshi ^{[1
]}

Koyano, Koji ^{[1
]}

Wada, Naohisa ^{[1
]}

Hirayama, Shigeto ^{[1
]}

Watanabe, Akio ^{[1
]}

Nemoto, Toru ^{[1
]}

Nakajima, Mayumi ^{[2
]}

Nakao, Kaoru ^{[2
]}

Mochizuki, Hidenori ^{[2
]}

Fujii, Hideaki ^{[1
]}

机构：

[1] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan

[2] Toray Industries Ltd, Pharmaceut Res Labs, Kanazawa, Ishikawa 2488555, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 20期

关键词：

Cap structure; Capped homotriplet; p-Toluenesulfonylmethyl isocyanide; Opioid; Antinociception; PROTEIN-COUPLED RECEPTORS; ANTAGONIST SELECTIVITY; REARRANGEMENT; NALTREXONE; DESIGN;

D O I：

10.1016/j.bmcl.2011.07.065

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

An improved synthetic method for triplet drugs with the 1,3,5-trioxazatriquinane skeleton was developed that used p-toluenesulfonylmethyl isocyanide (TosMIC) instead of 1,3-dithiane. Using the improved method, we synthesized compounds with two identical pharmacophore units and an epoxymethano group, that is, capped homotriplets. Among the synthesized capped homotriplets, KNT-123 showed high selectivity for the p receptor over the kappa receptor, and the mu selectivity was the highest among the reported p selective nonpeptide ligands. KNT-123 administered subcutaneously induced a dose-dependent analgesic effect in the acetic acid writhing assay, and its potency was 11-fold more potent than that of morphine. KNT-123 may serve as a useful tool for the study of the pharmacological actions mediated specifically via the mu receptor. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：6198 / 6202

页数：5

共 24 条

[21] Toll L, 1998, NIDA Res Monogr, V178, P440
[22] Opioid-receptor-heteromer-specific trafficking and pharmacology
van Rijn, Richard M.
Whistler, Jennifer L.
Waldhoer, Maria
[J]. CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (01) : 73 - 79
[23] Synthesis of a new opioid ligand having the oxabicyclo[3.2.1]octane skeleton using a new rearrangement reaction
Watanabe, Akio
Fujii, Hideaki
Nakajima, Mayumi
Hasebe, Ko
Mochizuki, Hidenori
Nagase, Hiroshi
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) : 2416 - 2419
[24] Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology: Part 1
Yamamoto, Naoshi
Fujii, Hideaki
Nemoto, Toru
Nakajima, Ryo
Momen, Shinobu
Izumimoto, Naoki
Hasebe, Ko
Mochizuki, Hidenori
Nagase, Hiroshi
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (13) : 4104 - 4107

← 1 2 3 →